TABLE 1

Comparison of Glucose Consumption Measurements with Analytic Methods by Regression Analysis with Those of NLR

Methodr2SlopeSEInterceptSE
T/N 40–60 min0.71258.107.251.4711.231
T/N 50–60 min0.70161.917.941.5921.348
SUVW, 40–60 min0.89830.541.940.7680.332
SUVWg, 40–60 min0.91034.772.060.0090.356
SUVLBM, 40–60 min0.84527.012.200.9870.376
SUVLBMg, 40–60 min0.92530.421.630.3260.279
SUVBSA, 40–60 min0.914765.544.3822.547.60
SUVBSAg, 40–60 min0.966*865.430.963.8135.30
SUVW, 50–60 min0.89832.112.040.7530.349
SUVWg, 50–60 min0.90836.532.19−0.0390.376
SUVLBM, 50–60 min0.84628.402.290.9860.392
SUVLBMg, 50–60 min0.92531.971.720.2960.294
SUVBSA, 50–60 min0.914804.846.6722.307.99
SUVBSAg, 50–60 min0.964*909.433.312.7675.71
Net influx constant (W)0.9101.0270.06100.011
Net influx constant (BSA)0.966*0.8710.0310.0040.005
SKM 40–60 min0.974*0.8930.0280.0070.005
SKM 50–60 min0.972*0.8910.0280.0060.005
Patlak (10–60 min) MRglu0.984*0.9310.0220.0040.004
Patlak (10–45 min) MRglu0.982*0.9410.0230.0040.004
Patlak (10–30 min) MRglu0.951*0.9590.0420.0090.007
Patlak (20–60 min) MRglu0.972*0.9210.0290.0080.005
Patlak (30–60 min) MRglu0.968*0.8930.0310.0130.005
TLE (0.5) MRglu0.63883.3111.83−4.0952.023
TLE (0.5) MRglu§0.6190.3180.0470.0410.008
TLE (0.6) MRglu0.65875.8410.33−4.2631.769
TLE (0.6) MRglu§0.6790.3700.0480.0480.008
TLE (0.7) MRglu0.67667.048.77−4.4021.502
TLE (0.7) MRglu§0.6990.4510.0560.0530.009
TLE (0.8) MRglu0.67953.716.97−4.1681.194
TLE (0.8) MRglu§0.8350.5770.0490.0620.008
TLE (0.9) MRglu0.53629.275.14−2.8000.881
TLE (0.9) MRglu§0.8150.7390.0800.0750.016
2-ROI, 6-parameter model0.4192.4060.556−0.0730.094
  • * r2 > 0.95.

  • Simplified kinetic method described by Hunter et al. (17).

  • Total lesion evaluation method described by Wu et al. (14).

  • § Correlative imaging method described by Zasadny et al. (15).

  • W = body weight; Wg = W plasma glucose; LBM = lean body mass; LBMg = LBM plasma glucose; BSA = body surface area; BSAg = BSA plasma glucose; MRglc = metabolic rate of glucose.